We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Skip to main content

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

SpringerLink
Log in

Lack of p53 expression in human myeloid leukemias is not due to mutations in transcriptional regulatory regions of the gene

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

References

  1. Vousden KH . p53: death star Cell 2000 103: 691–694

    Article  CAS  PubMed  Google Scholar 

  2. Stuart ET, Haffner R, Oren M, Gruss P . Loss of p53 function through PAX-mediated transcriptional repression EMBO J 1995 22: 5638–5645

    Article  Google Scholar 

  3. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S . Control of p53 transcription by HOXA5 may play a role in breast cancer Nature 2000 405: 974–978

    Article  CAS  PubMed  Google Scholar 

  4. Prokocimer M, Harris N, Brill E, Rotter V . Expression of p53 in human leukemia and lymphoma Rec Adv Leuk Lymph 1987 61: 243–264

    Google Scholar 

  5. Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja T . Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene Nature 1991 353: 83–86

    Article  CAS  PubMed  Google Scholar 

  6. Reisman D, Greenberg M, Rotter V . Human p53 oncogene contains one promoter upstream of exon 1 and a second stronger promoter within intron 1 Proc Natl Acad Sci USA 1988 85: 5146–5150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Nicole Doudican and Marna Hill for technical support and Kristy Boggs for discussions. Funding was from the NIH.

Author information

Authors and Affiliations

  1. Eli Lilly and Company, Indianapolis, IN, USA

    S Durland-Busbice

  2. Department of Biological Sciences, University of South Carolina, Columbia, SC, USA

    D Reisman

Authors
  1. S Durland-Busbice
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Reisman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Durland-Busbice, S., Reisman, D. Lack of p53 expression in human myeloid leukemias is not due to mutations in transcriptional regulatory regions of the gene. Leukemia 16, 2165–2167 (2002). https://doi.org/10.1038/sj.leu.2402647

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402647

  • Springer Nature Limited

This article is cited by

Search

Navigation